Bellicum Pharmaceuticals Inc reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bellicum Pharmaceuticals Inc using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-31 | $-0.20 | $-0.93 | 78.5 % |
Q3 | 2022-11-10 | $-0.23 | $-0.64 | 64.1 % |
Q2 | 2022-08-11 | $-0.13 | $-0.69 | 81.2 % |
Q2 | 2021-08-12 | $-0.22 | $-1.37 | 83.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2021-08-12 | $700.00K | $250.00K | 180.0 % |
Q4 | 2021-03-30 | $500.00K | $250.00K | 100.0 % |
Q2 | 2020-08-06 | $0 | $900.00K | -100.0 % |
Q4 | 2020-03-12 | $133.00K | $630.00K | -78.9 % |
Bellicum Pharmaceuticals Inc (BLCM) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3.
Bellicum Pharmaceuticals Inc (BLCM) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was $-0.02, which missed the estimate of $0.00.
Bellicum Pharmaceuticals Inc (BLCM) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual Revenue was $1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.